you would think a company with a 3 billion market cap all based on a 23 patient dose manipulated trial would want new data made public to justify the enormous valuation. Instead they say no more new patient data! And remove CC transcripts faster than some of their patients get diarrhea!
Meanwhile the analysts fiddle.
Well it's expected that dropouts will increase if the diarrheas continues and as the dose is increased it gets worse.. That's probably why only AEGR has a category called temporarily off the drug, aka dropped out for now, Meaning the real dropout rate is a lot higher than stated.
I would bet anything the othe 7 % will get it at the higher dosage.No wonder they have to constantly folllowed by a whole sle of doctors, nutritionisys etc. No wonder AEGR has stopped giving info on dropout numbers. What a canard..